JESSICA JACKSON: Open Payments
NPI 1750013439 · WARREN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 18 payments from 9 companies in 2025. Trend: 2023 $202 · 2024 $275 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $140 |
| ABBVIE INC. | 3 | $66 |
| Novo Nordisk Inc | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 2 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
Products named: FARXIGA, JARDIANCE, Ozempic, QULIPTA, HETLIOZ, BREZTRI, VRAYLAR, Auvelity.
Industry payments across AR — which companies pay providers there.
